SCHEMBL11396394

SCHEMBL11396394

C[C@@H](OCc1ccccc1)[C@](N)(C(=O)O)C(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.47
SLC1A2 P43004 2/20 0.47
SLC1A1 P43005 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
MEN1 O00255 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.39
HIF1A Q16665 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PSMB5 P28074 1/20 0.38
MAOB P27338 2/20 0.38
GLRA1 P23415 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27623951 0.81 SLC1A3 (0.44) SLC1A3SLC1A2SLC1A1KMT2ACYP1A2
SCHEMBL9756273 0.80 CES1 (0.45) KMT2ACYP1A2CYP2D6CYP2C19TDP1
SCHEMBL11401618 0.77 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1KMT2ACYP1A2
SCHEMBL3349927 0.76 CYP1A2 (0.52) CYP1A2CYP2D6CYP2C19TDP1SMN1; SMN2
SCHEMBL2689315 0.75 SLC1A3 (0.46) SLC1A3SLC1A2SLC1A1KMT2ACYP1A2
SCHEMBL10853441 0.74 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1KMT2ACYP1A2
SCHEMBL16634782 0.73 FABP5 (0.45) SLC1A3SLC1A2SLC1A1KMT2ACYP1A2
SCHEMBL4647195 0.72 ALDH1A1 (0.44) SLC1A3SLC1A2SLC1A1KMT2ACYP1A2
SCHEMBL3345739 0.72 CES1 (0.46) KMT2ACYP1A2CYP2D6CYP2C19NPC1
SCHEMBL6064499 0.72 ALDH1A1 (0.50) SLC1A3SLC1A2SLC1A1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0036713-A2 Angiotensin converting enzyme inhibitors UNIVERSITY OF MIAMI (US) 1981-09-30 EP disclosed